In a previous study, we demonstrated that EGF ointment is effective at managing EGFR inhibitor-related skin toxicities and improves patients’ QoL, compared with placebo, via a placebo-controlled, double-blind, multicenter, pilot phase III trial [21]. The gene discussed is EGFR; the disease is dermatological toxicity.